Background
Methods
Bacterial strains and growth conditions
Cranberry products, antibiotics and chemical reagents
Preparation of cranberry press cake extracts
Antibiotic susceptibility testing and synergy studies
Time-kill experiments
Transcriptional profiles
Quantitative PCR (qPCR)
Inhibition of macromolecular biosynthesis
Mouse mastitis model of infection
HPLC-MS analysis of cranberry fraction FC111
Statistical analysis
Results
The NC90 and the PC fraction FC111 are bactericidal and affect the transcription of genes associated with a cell wall stress
ORF SACOL | Gene name | Gene annotation | Fold expressionafor each strain | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ATCC 29213
|
MRSA N315
|
SHY97 4023
|
SHY97 3906
|
DAP
b
|
VAN
b
|
OXA
b
|
OBC
c
|
Vra
d
| |||
Up-regulated genes
| |||||||||||
0263 | Peptidoglycan hydrolase | 15.0 | 24.5 | 3.6 | 9.8 | + | = | = | = | ||
1066 |
fmt
| Fmt protein | 6.8 | 3.8 | 2.9 | 2.0 | + | + | + | + | + |
1459 | Methionine sulfoxide reductase | 2.3 | 6.0 | −1.5 | 1.2 | = | + | + | + | ||
1490 |
pbp2
| Penicillin binding protein 2 | 2.5 | 2.8 | 1.0 | 1.9 | + | + | + | + | + |
1777 |
htrA
| Putative serine protease Htra | 4.6 | 8.9 | 1.0 | 2.1 | + | + | + | = | |
1932 | Transglycosylase domain protein | 8.5 | 6.8 | 2.2 | 2.5 | + | = | = | + | + | |
1942 |
vraR
| DNA-binding response regulator | 8.8 | 10.9 | nd | 2.7 | + | + | + | = | + |
1943 |
vraS
| Sensor histidine kinase VraS | 14.2 | 10.5 | 7.6 | 4.0 | + | + | + | + | + |
1944 | Hypothetical protein | 5.1 | 7.5 | 1.3 | 1.4 | + | + | + | + | + | |
2017 |
groES
| Chaperonin | nd | 2.2 | 2.3 | 2.2 | + | + | + | = | |
2116 |
mur AB | UDP-N-AcGlc-1-carbotransferase | 4.0 | 7.6 | 2.5 | 2.6 | + | + | + | + | + |
2291 | Staphyloxanthin biosynthesis | 6.0 | 2.2 | 4.5 | 3.9 | – | – | – | = | ||
2352 |
tcaA
| TcaA protein | 5.1 | 6.3 | 1.1 | 1.4 | + | + | + | + | + |
2584 |
isaA
| Immunodominant antigen A | 2.1 | 1.8 | 2.3 | 2.1 | = | = | = | = | |
Down-regulated genes
| |||||||||||
0095 |
spa
| IgG binding protein | −33.3 | −2.0 | −37.5 | nd | – | = | = | ||
0096 |
sarS
| Accessory regulator | −2.0 | −2.9 | −2.7 | −2.2 | – | – | – | ||
0136-0150e
|
capA-O
| Capsular polysaccharide | −4.9 | nd | −3.1 | −1.9 | – | = | – | ||
0317 | Lipase precursor | −8.6 | −6.8 | −4.1 | −1.7 | – | – | = | |||
451-452e
|
ahpFC
| Alkyl hydroperoxide reductase | −3.4 | −3.6 | −8.2 | −1.2 | = | = | – | ||
0679 | Na+/H+ antiporter, MnhA | −4.5 | −10.0 | −13.0 | −25.0 | = | = | = | |||
0688-0690e
|
mntABC
| ABC transporter | −43.5 | −66.7 | −86.7 | −91.7 | – | = | = | ||
0765-0766e
|
saeSR
| Sensor/Histidine kinase | −1.5 | −3.7 | −1.5 | −3.6 | = | = | = | ||
1072 |
folD
| THF dehydrogenase | −2.1 | −2.6 | −2.7 | nd | = | = | = | ||
1079 |
purF
| amidophosphoribosyltransferase | nd | −10.0 | −0.8 | −2.6 | = | – | – | ||
1140 |
isdA
| Heme-iron transport | −5.3 | −2.1 | −2.9 | nd | – | = | = | ||
1158-1160e
|
sdhABC
| Succinate dehydrogenase | −5.1 | −7.9 | −4.5 | −3.8 | – | – | = | ||
1173 |
hla
| Alpha-hemolysin | −3.6 | −4.3 | nd | −2.6 | – | = | = | ||
1262-1263e
|
sucCD
| Succinyl-CoA synthetase | −5.6 | −3.1 | −6.4 | −2.3 | = | = | = | ||
1328 |
glnR
| Glutamine synthetase repressor | −3.7 | −6.3 | −3.4 | −5.3 | – | – | = | ||
1329 |
femC
| Glutamine synthetase FemC | −2.7 | −4.2 | −3.2 | −2.9 | – | = | = | ||
1368 |
katA
| Catalase | −3.2 | −2.4 | −5.2 | −2.1 | = | + | = | ||
1385 |
acnA
| Aconitate hydratase | −3.4 | −3.0 | −6.3 | nd | = | = | = | ||
1396 |
fmtC
| FmtC protein | −0.9 | −2.4 | −2.0 | nd | – | – | – | ||
1448-1449e
|
sucAB
| 2-oxoglutarate dehydrogenase | −8.1 | −5.4 | −4.8 | −4.9 | = | = | = | ||
1741 |
icd
| Isocitrate dehydrogenase, NADP | −5.6 | −2.2 | −11.5 | −2.5 | = | = | + | ||
1742 |
gtlA
| Citrate synthase | −6.7 | −2.3 | −14.3 | −2.2 | = | = | + | ||
1743 | Amino acid permease | −3.1 | −1.2 | −4.8 | −1.5 | = | = | = | |||
2055 |
rsbW
| Anti-sigma B factor | −2.6 | nd | −1.6 | −2.1 | – | = | – | ||
2057 |
rsbU
| Sigma factor B regulator protein | −1.3 | −3.1 | −0.9 | −2.1 | = | = | – | ||
2066-2068e
|
kdpABC
| Potassium-transporting ATPase | −3.5 | nd | −2.3 | −1.7 | = | = | = | ||
2293 | NAD/NADP dehydrogenase | −2.0 | −2.4 | −1.3 | nd | – | = | – | |||
2694 |
geh
| lipase | −27.3 | −4.3 | −20.0 | nd | = | = | = |
FC111 inhibits cell wall biosynthesis
In Vitro bactericidal effect of FC111 and β-lactam antibiotic combinations
S. aureus strains | Antibiotic | MIC of antibiotic in μg/mL in the presence of an increasing concentration of the cranberry fraction FC111, also in μg/mL (fold decrease in antibiotic MIC)a
| ||||
---|---|---|---|---|---|---|
0
|
32
|
64
|
128
|
256
| ||
ATCC 29213 | amoxicillin | 0.06 | 0.06 (1×) | 0.06 (1×) | 0.015 (4×) | 0.015 (4×) |
MRSA COL | 512 | 4 (128×) | 4 (128×) | 1 (512×) | 1 (512×) | |
ATCC 29213 | oxacillin | 0.5 | 0.06 (8×) | 0.03 (16×) | 0.03 (16×) | 0.03 (16×) |
MRSA COL | 512 | 256 (2×) | 128 (4×) | 32 (16×) | 16 (32×) |
The FC111-amoxicillin combination improves bacterial clearance in mammary glands
HPLC-MS analysis of cranberry fraction FC111
Peak | tR(min)a
| λmax (nm)b
| MW (Da)c
| Putative identification | Relative abundanced
|
---|---|---|---|---|---|
1a,b | 4.8 | 192 | quinic acid | ||
Iridoids
| |||||
2a,b | 6.5 | 235 | 390 | monotropein | 18.5 ± 0.78% |
3 | 7.3 | 235 | 392 | 6,7-dihydromonotropein | 26.8 ± 0.07% |
16b | 14.4 | 235 | 416 | unknown monotropein derivative | 54.8 ± 0.99% |
Total (vs. A254 nm) | 22 % | ||||
Monophenolic acids
| |||||
4 | 8.7 | 280 | 220 | unknown benzoic acid derivative | 3.1 ± 0.51% |
5 | 8.9 | 280 | unknown benzoic acid derivative | 0.52 ± 0.06% | |
6 | 9.7 | 290 | 162 | unknown benzoic acid derivative | 0.78 ± 0.10% |
7 | 9.8 | 290 | unknown benzoic acid derivative | 1.18 ± 0.11% | |
8 | 10.4 | 275 | 316 | dihydroxybenzoic acid glycoside | 3.45 ± 0.29% |
9a,b | 11.6 | 285, 320 | 342 | caffeic acid glycoside | 3.06 ± 0.45% |
10 | 12.0 | 275 | 300 | hydroxybenzoic acid glycoside | 0.72 ± 0.16% |
11 | 12.3 | 295, 305 | 326 | coumaric acid glycoside isomer 1 | 14.04 ± 0.49% |
12 | 12.4 | 275 | 238 | unknown benzoic acid derivative | 1.45 ± 0.049% |
13 | 13.6 | 315 | 326 | coumaric acid glycoside isomer 2 | 15.1 ± 0.40% |
14 | 13.8 | 285, 310 | 326 | coumaric acid glycoside isomer 3 | 16.1 ± 0.56% |
15 | 14.1 | 295, 325 | unknown hydroxycinnamic acid | 7.22 ± 0.092% | |
16a | 14.4 | 280 | 284 | benzoyl-glycoside | 5.44 ± 0.89% |
17 | 14.7 | 285, 330 | 356 | ferulic acid-glycoside | 5.59 ± 0.21% |
18 | 15.0 | 275 | unknown benzoic acid derivative | 13.24 ± 0.13% | |
19 | 15.3 | 280, 330 | 386 | sinapinic acid-glycoside | 7.47 ± 0.28% |
20a,b | 16.3 | 280 | unknown benzoic acid derivative | 1.50 ± 0.69% | |
Total (vs. A254 nm) | 9% | ||||
Anthocyanins
| |||||
21 | 16.8 | 525 | 465 | delphinidin-3-O-galactoside | 0.40 ± 0.00% |
24 | 18.0 | 518 | 449 | cyanidin-3-O-galactoside | 18.4 ± 0.01% |
25 | 18.2 | 525 | 435 | delphinidin-3-O-arabinoside | 0.60 ± 0.03% |
26 | 19.0 | 515 | 433 | pelargonidin-3-O-galactoside | 0.28 ± 0.00% |
27 | 19.3 | 520 | 419 | cyanidin-3-O-arabinoside | 11.2 ± 0.00% |
28 | 19.8 | 520 | 463 | peonidin-3-O-galactoside | 43.3 ± 0.03% |
29 | 20.4 | 524 | 493 | malvidin-3-O-galactoside | 7.64 ± 0.00% |
31 | 21.1 | 521 | 433 | peonidin-3-O-arabinoside | 15.5 ± 0.01% |
33 | 21.6 | 530 | 463 | malvidin-3-O-arabinoside | 1.79 ± 0.00% |
Total (vs. A254 nm) | 40% | ||||
Flavonols
| |||||
30 | 20.5 | 370 | 450 | myricetin-3-O-arabinoside | 4.05 ± 0.34% |
32 | 21.3 | 360 | 464 | quercetin-3-O-galactoside | 50.2 ± 0.11% |
34 | 22.0 | 354 | 434 | quercetin-3-O-xyloside | 7.71 ± 0.00% |
35 | 22.3 | 352 | 434 | quercetin-3-O-arabinopyranoside | 3.72 ± 0.02% |
36 | 22.8 | 354 | 434 | quercetin-3-O-arabinofuranside | 13.65 ± 0.12% |
37 | 23.3 | 352 | 448 | quercetin-3-O-rhamnoside | 2.87 ± 0.01% |
38 | 23.6 | 356 | 478 | isorhamnetin-3-O-galactoside | 5.31 ± 0.04% |
39 | 24.0 | 360 | 508 | syringetin-3-O-galactoside | 4.70 ± 0.05% |
40 | 24.7 | 360 | unknown flavonol derivative | 0.46 ± 0.02% | |
41 | 25.0 | 355 | 448 | isorhamnetin-3-O-arabinoside | 1.55 ± 0.01% |
42a,b | 25.6 | 355 | 610 | quercetin-3-O-(6”coumaroyl)-galactoside | 2.27 ± 0.04% |
43 | 26.1 | 355 | 478 | syringetin-3-O-arabinoside | 2.04 ± 0.04% |
44 | 27.5 | 356 | 568 | quercetin-3-O-(6” benzoyl)-galactoside | 1.48 ± 0.02% |
Total (vs. A254 nm) | 25% |